{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T09:24:17Z","timestamp":1777886657864,"version":"3.51.4"},"reference-count":12,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T00:00:00Z","timestamp":1770768000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Infectious Diseases Now"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.idnow.2026.105257","type":"journal-article","created":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T00:29:15Z","timestamp":1771028955000},"page":"105257","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Temocillin for non-urinary tract infections caused by AmpC-producing Enterobacterales: Is it a feasible option?"],"prefix":"10.1016","volume":"56","author":[{"given":"Christel","family":"Mamona-Kilu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bui Hai","family":"Hoang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3243-8018","authenticated-orcid":false,"given":"Eric","family":"Farfour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5843-4819","authenticated-orcid":false,"given":"Aur\u00e9lien","family":"Dinh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.idnow.2026.105257_b0005","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.ijmm.2010.04.005","article-title":"Resistance to cephalosporins and carbapenems in Gram-negative bacterial pathogens","volume":"300","author":"Pfeifer","year":"2010","journal-title":"Int J Med Microbiol"},{"key":"10.1016\/j.idnow.2026.105257_b0010","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.ijantimicag.2011.01.012","article-title":"What remains against carbapenem-resistant Enterobacteriaceae? Evaluation of chloramphenicol, ciprofloxacin, colistin, fosfomycin, minocycline, nitrofurantoin, temocillin and tigecycline","volume":"37","author":"Livermore","year":"2011","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.idnow.2026.105257_b0015","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1093\/jac\/dkn511","article-title":"Temocillin revived","volume":"63","author":"Livermore","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.idnow.2026.105257_b0020","doi-asserted-by":"crossref","DOI":"10.1093\/jacamr\/dlae171","article-title":"Real-life use of temocillin in the treatment of bone and joint infections due to extended spectrum \u03b2-lactamase-producing Enterobacterales","volume":"6","author":"Lahouati","year":"2024","journal-title":"JAC Antimicrob Resist"},{"key":"10.1016\/j.idnow.2026.105257_b0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.106223","article-title":"Temocillin susceptibility in Enterobacterales with an ESBL\/AmpC phenotype","volume":"57","author":"Kresken","year":"2021","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.idnow.2026.105257_b0030","article-title":"Real-life temocillin use in Greater Paris area, effectiveness and risk factors for failure in infections caused by ESBL-producing Enterobacterales: a multicentre retrospective study","volume":"5","author":"Dinh","year":"2023","journal-title":"JAC Antimicrob Resist"},{"key":"10.1016\/j.idnow.2026.105257_b0035","doi-asserted-by":"crossref","DOI":"10.1093\/jacamr\/dlae164","article-title":"Effectiveness of temocillin in treatment of non-urinary tract infections caused by ESBL-producing Enterobacterales and risk factors for failure","volume":"6","author":"Mamona Kilu","year":"2024","journal-title":"JAC Antimicrob Resist"},{"key":"10.1016\/j.idnow.2026.105257_b0040","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1093\/jac\/dkae449","article-title":"Temocillin efficacy against AmpC \u03b2-lactamase-producing Enterobacterales: a relevant alternative to cefepime?","volume":"80","author":"Brousse","year":"2025","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.idnow.2026.105257_b0045","doi-asserted-by":"crossref","DOI":"10.1093\/jacamr\/dlad114","article-title":"Impact of revised breakpoints on the categorization of susceptibility of Enterobacterales to temocillin","volume":"5","author":"Farfour","year":"2023","journal-title":"JAC Antimicrob Resist"},{"key":"10.1016\/j.idnow.2026.105257_b0050","doi-asserted-by":"crossref","DOI":"10.1093\/jacamr\/dlac086","article-title":"Clinical and microbiological evaluation of temocillin for bloodstream infections with Enterobacterales: a Belgian single-centre retrospective study","volume":"4","author":"Oosterbos","year":"2022","journal-title":"JAC Antimicrob Resist"},{"key":"10.1016\/j.idnow.2026.105257_b0055","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1093\/jac\/dkr317","article-title":"Temocillin use in England: clinical and microbiological efficacies in infections caused by extended-spectrum and\/or derepressed AmpC \u03b2-lactamase-producing Enterobacteriaceae","volume":"66","author":"Balakrishnan","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.idnow.2026.105257_b0060","doi-asserted-by":"crossref","first-page":"859","DOI":"10.3390\/antibiotics14090859","article-title":"Temocillin: a narrative review of its clinical reappraisal","volume":"14","author":"Cosimi","year":"2025","journal-title":"Antibiotics (Basel)"}],"container-title":["Infectious Diseases Now"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266699192600014X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266699192600014X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T03:46:28Z","timestamp":1777607188000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S266699192600014X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":12,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S266699192600014X"],"URL":"https:\/\/doi.org\/10.1016\/j.idnow.2026.105257","relation":{},"ISSN":["2666-9919"],"issn-type":[{"value":"2666-9919","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Temocillin for non-urinary tract infections caused by AmpC-producing Enterobacterales: Is it a feasible option?","name":"articletitle","label":"Article Title"},{"value":"Infectious Diseases Now","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.idnow.2026.105257","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"105257"}}